美股市场个股详情
ACIU AC Immune
- 3.360
- -0.040-1.18%
收盘价 11/27 16:00 (美东)
3.32亿总市值-7417市盈率TTM
3.430最高价3.350最低价6.14万股成交量3.430今开3.400昨收20.69万成交额0.16%换手率亏损市盈率(静)9894.31万总股本5.14052周最高2.26市净率1.33亿流通值2.25052周最低--股息TTM3967.52万流通股19.970历史最高--股息率TTM2.35%振幅1.680历史最低3.372平均价1股每手
关于AC Immune公司
AC Immune SA 是一家临床阶段的生物制药公司，专注于神经退行性疾病的研究。该公司利用其专有的技术平台来发现、设计和开发针对与蛋白质错误折叠相关的神经退行性疾病的预防、诊断和治疗的新型专有小分子、抗体和疫苗。公司拥有一个业务部门。目前，公司将大部分资源集中在发现和开发针对错误折叠蛋白的治疗和诊断产品上。公司的管线产品包括ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056以及其他产品。
公司介绍
公司代码ACIU
公司名称AC Immune
上市日期2016/09/23
发行价格11.00
成立日期2003
CEODr. Andrea Pfeifer, PhD
所属市场纳斯达克
员工数量161
年结日12-31
公司地址EPFL Innovation Park,Building B
城市Lausanne
省份沃州
国家瑞士
邮编1015
电话41-21-345-91-21
董事高管
- 姓名
- 职务
- 年薪
- Dr. Andrea Pfeifer, PhD
- Chief Executive Officer and Director
- --
- Christopher Roberts
- Chief Financial Officer
- --
- Dr. Madiha Derouazi, PhD
- Chief Scientific Officer
- --
- Piergiorgio Donati
- Chief Technical Operations Officer
- --
- Jean-Fabien Monin
- Chief Administrative Officer
- --
- Howard Donovan
- Chief Human Resources Officer
- --
- Dr. Nuno Mendonça, M.D.
- Chief Medical Officer
- --
- Dr. Julien Rongere, PhD
- Senior Vice President, Regulatory Affairs and Quality Assurance
- --
- Dr. Olivier Sol, M.D.
- Vice President and Head of Clinical Development
- --
- Mark Danton
- Senior Vice President Information Systems and Artificial Intelligence
- --
- Dr. Gary Waanders, PhD
- Senior Vice President, Investor Relations and Corporate Communications
- --
- Dr. Bojana Portmann, PhD
- Vice President, IP and Business Development
- --
- Professor Dr. Monika Butler, PhD
- Vice Chairman of the Board and Director
- --
- Dr. Douglas E. WilliaPhD
- Chairman of the Board
- --
- Monica Shaw
- Independent Director
- --
- Professor Carl June, M.D.
- Independent Director
- --
- Dr. Werner Lanthaler, PhD
- Independent Director
- --
- Dr. Roy Twyman, M.D.
- Independent Director
- --
- Alexandre Caratsch
- General Counsel
- --
- Dr. Julian Gray, PhD
- Clinical Advisor
- --
- Dr. Marie Kosco-Vilbois, PhD
- Scientific Advisor
- --
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据